We continue to expand and welcome Robert Lindberg

We are happy to announce that Robert Lindberg has joined our team. Robert recently graduate from Stockholm University in Degree of Master of Science with a Major in Molecular Biology. “It feels great to be a part of Scandinavian Biopharma. It’s really motivating to work with the development of a new vaccine that can contribute […]

Scandinavian Biopharma expand their portfolio with Coagadex® – the first and only tailormade treatment for the rare bleeding disorder ‘factor X deficiency’

Scandinavian Biopharma has entered into a distribution agreement with Bio Products Laboratory Limited (BPL), a leading manufacturer of plasma-derived protein therapies, for their unique factor X deficiency product Coagadex®. Coagadex® is the first and only tailormade treatment for factor X deficiency bleeding disorder in Europe. Coagadex® is indicated for the treatment and prophylaxis of bleeding […]

Promising preliminary findings from a Phase 2b study of the oral vaccine ETVAX® against travelers’ diarrhea in Finnish travelers to Benin, West Africa

Today, Scandinavian Biopharma reports on encouraging new results from a Phase 2b study of the oral, inactivated vaccine candidate ETVAX® against enterotoxigenic Escherichia coli (ETEC), the most frequent cause of travelers’ diarrhea and enteric illness among infants and young children in low-resource settings. The trial enrolled adult volunteers from Finland who travelled to Grand Popo, […]

Scandinavian Biopharma recruits Anna Hill as Clinical Operations Manager

Scandinavian Biopharma is now strengthening its organization by recruiting Anna Hill to the new position as Clinical Operations Manager. The company is in late clinical development phase with several ongoing clinical studies for the ETEC vaccine candidate ETVAX®. Anna will have the overall responsibility for the company’s clinical development program and be responsible for ensuring […]

The science is clear – let us highlight and support ‘World Immunization Week’

Last week in April is the ‘World Immunization Week’. As the world unites against Covid-19, we are reminded of how quickly emerging and new diseases can spread when there is no immunity or vaccine to protect. Vaccines, when they are available, are the most effective tool to control and eliminate life-threatening infectious diseases. Vaccination saves […]

Scandinavian Biopharma is once again looking back on a very successful business year

Scandinavian Biopharma can look back on a very successful 2019! The company was granted 10.6 MEUR from the EDCTP for a phase III trial of the ETEC vaccine candidate ETVAX® in children in Low- and Middle-Income Countries (LMIC). Impressive clinical results from Phase I/II study in Bangladesh were published. A late phase African paediatric development […]



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.